David S. Block, M.D., has been appointed executive vice president of international operations at DuPont Pharmaceuticals. Previously, Block served as senior vice president of business development and strategic planning. In his new role, he will have
David S. Block, M.D., has been appointed executive vice president of international operations at DuPont Pharmaceuticals. Previously, Block served as senior vice president of business development and strategic planning. In his new role, he will have responsibility for profit and loss in all regions outside the U.S. and will be charged with growing these businesses. Block joined the company in 1990 as a product development manager for central nervous system products. He is also an assistant professor of medicine at Johns Hopkins Hospital in Baltimore and a member of the active attending staff in the Moore Clinic for HIV patients.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.